Antimicrobial resistance (AMR) poses a serious global health threat, with 1.27 million deaths in 2019 linked to resistant bacteria. Bacteriophages, viruses that target bacteria, present potential alternatives to antibiotics due to their specificity, self-replicating capability, and lower side effects. However, challenges such as specificity limits and safety concerns remain, prompting ongoing research into phage therapy.